THE GUT–BRAIN AXIS IN NEURODEGENERATIVE DISEASES: LINKING MICROBIOTA DYSBIOSIS, BARRIER DYSFUNCTION, AND NEUROINFLAMMATION
DOI:
https://doi.org/10.59003/nhj.v6i2.2313Keywords:
gut–brain axis; gut microbiota; dysbiosis; neuroinflammation; neurodegenerative diseases; blood–brain barrier; microbiome; microgliaAbstract
Neurodegenerative diseases (NDDs), including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and amyotrophic lateral sclerosis, are characterized by progressive neuronal dysfunction and loss. Neuroinflammation, immune dysregulation, oxidative stress, and mitochondrial dysfunction are increasingly recognized as interconnected mechanisms in disease progression. The gut–brain axis provides a bidirectional link between the gastrointestinal tract and central nervous system through neural, immune, endocrine, and metabolic pathways. Gut microbiota dysbiosis may contribute to neurodegeneration through impaired intestinal barrier integrity, altered microbial metabolites, systemic inflammation, and blood–brain barrier dysfunction. Changes in short-chain fatty acids, tryptophan-derived metabolites, bile acids, and microbial products such as lipopolysaccharide may modulate immune and glial signaling, including TLR4/NF-κB and NLRP3 pathways. Evidence is particularly prominent in Alzheimer’s and Parkinson’s diseases, although microbial alterations remain heterogeneous across studies. The gut–brain axis represents a potentially modifiable interface linking microbial dysbiosis and neuroinflammation. Microbiome-targeted interventions show promising but inconsistent results. Further integration of microbiomics, metabolomics, immunophenotyping, and longitudinal clinical data is needed to establish causality and advance precision strategies for neurodegenerative diseases.
Downloads
References
Abdullah, D., Poddar, S., Rai, R. P., Purwati, E., Dewi, N. P., & Pratama, Y. E. (2021). Identifikasi molekuler bakteri asam laktat sebagai pendekatan untuk ketahanan pangan berkelanjutan. Journal of Public Health Research, 10(2_suppl). https://doi.org/10.4081/jphr.2021.2508
Chen, Q., Shi, J., Yu, G., Xie, H., Yu, S., Xu, J., Liu, J., & Sun, J. (2024). Gut microbiota dysbiosis in patients with Alzheimer’s disease and correlation with multiple cognitive domains. Frontiers in Aging Neuroscience, 16, 1478557. https://doi.org/10.3389/fnagi.2024.1478557
Chui, Z. S. W., Chan, L. M. L., Zhang, E. W. H., Liang, S., Choi, E. P. H., Lok, K. Y. W., Tun, H. M., & Kwok, J. Y. Y. (2024). Effects of microbiome-based interventions on neurodegenerative diseases: A systematic review and meta-analysis. Scientific Reports, 14, 9558. https://doi.org/10.1038/s41598-024-59250-w
Dandamudi, B., Dimaano, K. M., Shah, N., et al. (2024). Neurodegenerative disorders and the gut-microbiome-brain axis: A literature review. Cureus, 16(10), e72427. https://doi.org/10.7759/cureus.72427
Dissanayaka, S., et al. (2025). Changes in gut microbiota and short-chain fatty acids in different stages of Alzheimer’s disease. Alzheimer’s & Dementia. https://doi.org/10.1002/alz70855_105512
Fu, Y., Gu, Z., Cao, H. C., Zuo, C., Huang, Y., Song, Y., Jiang, Y., & Wang, F. (2024). The role of the gut microbiota in neurodegenerative diseases targeting metabolism. Frontiers in Neuroscience, 18, 1432659. https://doi.org/10.3389/fnins.2024.1432659
Jia, X., Wang, Q., Liu, M., & Ding, J. (2024). The interplay between gut microbiota and the brain-gut axis in Parkinson’s disease treatment. Frontiers in Neurology, 15, 1415463. https://doi.org/10.3389/fneur.2024.1415463
Kang, et al. (2025). Gut microbiome compositional and functional features associate with Alzheimer’s disease pathology. Alzheimer’s & Dementia. https://doi.org/10.1002/alz.70417
Kuehn, M., et al. (2024). Relationships between microbiome-derived short chain fatty acids and Alzheimer’s disease pathology biomarkers: A human cohort study. Alzheimer’s & Dementia. https://doi.org/10.1002/alz.094882
Li, Q., Meng, L. B., Chen, L. J., Shi, X., Tu, L., Zhou, Q., Yu, J. L., Liao, X., Zeng, Y., & Yuan, Q. Y. (2023). The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson’s disease. Frontiers in Neurology, 14, 1185375. https://doi.org/10.3389/fneur.2023.1185375
Li, S., Cai, Y., Wang, S., Luo, L., Zhang, Y., Huang, K., & Guan, X. (2024). Gut microbiota: The indispensable player in neurodegenerative diseases. Journal of the Science of Food and Agriculture, 104(12), 7096–7108. https://doi.org/10.1002/jsfa.13509
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024). Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduction and Targeted Therapy, 9, 37. https://doi.org/10.1038/s41392-024-01743-1
Murray, E. R., Kemp, M., & Nguyen, T. T. (2022). The microbiota-gut-brain axis in Alzheimer’s disease: A review of taxonomic alterations and potential avenues for interventions. Archives of Clinical Neuropsychology, 37(3), 595–607. https://doi.org/10.1093/arclin/acac008
Ning, M., An, L., Dong, L., Zhu, R., Hao, J., Liu, X., & Zhang, Y. (2024). Causal associations between gut microbiota, gut microbiota-derived metabolites, and Alzheimer’s disease: A multivariable Mendelian randomization study. Journal of Alzheimer’s Disease, 100(1), 229–237. https://doi.org/10.3233/JAD-240082
Nishiwaki, H., Ueyama, J., Ito, M., Hamaguchi, T., Takimoto, K., Maeda, T., Kashihara, K., Tsuboi, Y., Mori, H., Kurokawa, K., Katsuno, M., Hirayama, M., & Ohno, K. (2024). Meta-analysis of shotgun sequencing of gut microbiota in Parkinson’s disease. npj Parkinson’s Disease, 10, 106. https://doi.org/10.1038/s41531-024-00724-z
Radhakrishnan, P., Viswanathan, K., Lini, S., Chinta, S., & Muthusamy, S. (2025). Unveiling role of gut microbiota in Alzheimer’s disease: Mechanisms, challenges and future perspectives. Current Alzheimer Research, 22(10), 711–725. https://doi.org/10.2174/0115672050403066250904112611
Stagaman, K., Kmiecik, M. J., Wetzel, M., Aslibekyan, S., Filshtein Sonmez, T., Fontanillas, P., 23andMe Research Team, Tung, J., Holmes, M. V., Walk, S. T., & Houser, M. C. (2024). Oral and gut microbiome profiles in people with early idiopathic Parkinson’s disease. Communications Medicine.
Warren, A., Wynia, Z., Corr, P. G., Devin, M. F., Celikkol, Z., Gordon, L., Farah, M., Karam, M., Villarreal, D., Jackson, S. A., & Frame, L. A. (2026). The microbiota–gut–brain axis in mild cognitive impairment and Alzheimer’s disease: A scoping review of human studies. Alzheimer’s & Dementia, 22(1), e71023. https://doi.org/10.1002/alz.71023
Zhang, W., Ye, Y., Song, J., Sang, T., Xia, T., Xie, L., Qiu, X., Zeng, Q., & Luo, X. (2023). Research progress of microbiota-gut-brain axis in Parkinson’s disease. Journal of Integrative Neuroscience, 22(6), 157. https://doi.org/10.31083/j.jin2206157
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Lina Eka Dewi
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
NHJ is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Articles in this journal are Open Access articles published under the Creative Commons CC BY-NC-SA License This license permits use, distribution and reproduction in any medium for non-commercial purposes only, provided the original work and source is properly cited.
Any derivative of the original must be distributed under the same license as the original.
